Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 158-163 , July 2006

When and How Should Adjuvant Radiation Be Used in Early Endometrial Cancer?

  • Kaled M. Alektiar, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Kaled M. Alektiar, MD, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

References 

  1. Piver M , Hempling R . A prospective trial of post-operative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma . Cancer . 1990;66:1133–1138
  2. Randall ME , Wilder J , Greven K , et al.   Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma . Int J Radiat Oncol Biol Phys . 1990;19:49–54
  3. Orr JW , Holimon JL , Orr PF . Stage I corpus cancer (is teletherapy necessary?) . Am J Obstet Gynecol . 1997;176:777–788
  4. Mohan DS , Samuels MA , Selim MA , et al.   Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma . Gynecol Oncol . 1998;70:165–171
  5. Straughn JM , Huh WK , Kelly FJ , et al.   Conservative management of stage I endometrial carcinoma after surgical staging . Gynecol Oncol . 2002;84:194–200
  6. Creutzberg CL , van Putten WL , Koper PC , et al.  PORTEC Study Group   Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma (Multicentre randomised trial. Post Operative Radiation Therapy in Endometrial Carcinoma) . Lancet . 2000;355:1404–1411
  7. Keys HM , Roberts JA , Brunetto VL , et al.   A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma (A Gynecologic Oncology Group study) . Gynecol Oncol . 2004;92:744–751
  8. Creutzberg CL , van Putten WL , Koper PC , et al.   Survival after relapse in patients with endometrial cancer (results from a randomized trial) . Gynecol Oncol . 2003;89:201–209
  9. Creutzberg CL , van Putten WL , Koper PC , et al.   The morbidity of treatment for patients with stage I endometrial cancer (Results from a randomized trial) . Int J Radiat Oncol Biol Phys . 2001;51:1246–1255
  10. Sears J , Greven K , Hoen HM , et al.   Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer . Cancer . 1994;74:1303–1308
  11. Wylie J , Irwin C , Pintilie M , et al.   Results of radical radiotherapy for recurrent endometrial cancer . Gynecol Oncol . 2000;77:66–72
  12. Jhingran A , Burke TW , Eifel PJ . Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy . Int J Radiat Oncol Biol Phys . 2003;56:1366–1372
  13. Lilie L , Lin LL , Perry W , et al.   Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer . Int J Radiat Oncol Biol Phys . 2005;63:500–504
  14. Mariani A , Dowdy SC , Keeney GL , et al.   Predictors of vaginal relapse in stage I endometrial cancer . Gynecol Oncol . 2005;97:820–827
  15. Scholten AN , van Putten WLJ , Beerman H , et al.   Postoperative radiotherapy for stage 1 endometrial carcinoma (Long-term outcome of the randomized PORTEC trial with central pathology review) . Int J Radiat Oncol Biol Phys . 2005;63:834–838
  16. MacLeod C , Fowler A , Duval P , et al.   High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer . Int J Radiat Oncol Biol Phys . 1998;42:1033–1039
  17. Petereit DG , Tannehill SP , Grosen EA , et al.   Outpatient vaginal cuff brachytherapy for endometrial cancer . Int J Gynecol Cancer . 1999;9:456–462
  18. Alektiar KM , Venkatraman E , Chi DS , et al.   Intravaginal brachytherapy alone for intermediate-risk endometrial cancer . Int J Radiat Oncol Biol Phys . 2005;62:111–117
  19. Jolly S , Vargas C , Kumar T , et al.   Vaginal brachytherapy alone (An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer) . Gynecol Oncol . 2005;97:887–892
  20. Sorbe BG , Smeds AC . Postoperative vaginal irradiation with high dose-rate afterloading technique in endometrial carcinoma stage I . Int J Radiat Oncol Biol Phys . 1990;18:305–314
  21. Onsrud M , Strickert T , Marthinsen AB . Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer (A comparison of standardized and individualized target volumes) . Int J Radiat Oncol Biol Phys . 2001;49:749–755
  22. Sorbe B , Straumits A , Karlsson L . Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer (A randomized study of two dose-per-fraction levels) . Int J Radiat Oncol Biol Phys . 2005;62:1385–1389
  23. Anderson JM , Stea B , Hallum AV , et al.   High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer . Int J Radiat Oncol Biol Phys . 2000;46:417–425
  24. Solhjem MC , Petersen IA , Haddock MG . Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer . Int J Radiat Oncol Biol Phys . 2005;62:1379–1384
  25. Alektiar KM , McKee A , Venkatraman E , et al.   Intravaginal high-dose-rate brachytherapy for stage IB (FIGO Grade 1, 2) endometrial cancer . Int J Radiat Oncol Biol Phys . 2002;53:707–713
  26. Aalders J , Abeler V , Kolstad P , et al.   Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma (Clinical and histopathologic study of 540 patients) . Obstet Gynecol . 1980;56:419–427
  27. Chadha M , Nanavati PJ , Liu P , et al.   Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy . Gynecol Oncol . 1999;75:103–107
  28. Horowitz NS , Peters WA , Smith MR , et al.   Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma . Obstet Gynecol . 2002;99:235–240
  29. Portelance L , Chao CL , Grigsby PW , et al.   Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation . Int J Radiat Oncol Biol Phys . 2001;51:261–266
  30. Roeske JC , Lujan A , Rotmensch J , et al.   Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies . Int J Radiat Oncol Biol Phys . 2000;48:1613–1621
  31. Mundt AJ , Lujan AE , Rotmensch J , et al.   Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies . Int J Radiat Oncol Biol Phys . 2002;52:1330–1337
  32. Mundt AJ , Mell LK , Roeske JC . Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy . Int J Radiat Oncol Biol Phys . 2003;56:1354–1360
  33. Brixey CJ , Roeske JC , Lujan AE , et al.   Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies . Int J Radiat Oncol Biol Phys . 2002;54:1388–1396
  34. Greven KM , D’Agostino RB , Lanciano RM , et al.   Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? . Int J Radiat Oncol Biol Phys . 1998;42:101–104
  35. Fanning J . Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy . Gynecol Oncol . 2001;82:371–374
  36. Ng TY , Nicklin JL , Perrin LC , et al.   Postoperative vaginal vault brachytherapy for node-negative stage II (occult) endometrial carcinoma . Gynecol Oncol . 2001;81:193–195
  37. Rittenberg PV , Lotocki RJ , Heywood MS , et al.   Stage II endometrial carcinoma (Limiting post-operative radiotherapy to the vaginal vault in node-negative tumors) . Gynecol Oncol . 2005;98:434–438

PII: S1053-4296(06)00005-1

doi: 10.1016/j.semradonc.2006.02.004

Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 158-163 , July 2006

Article Tools